Introduction
============

Postoperative analgesia after total knee arthroplasty (TKA) is challenging. Inadequate pain relief is associated with peri-operative complications, difficult rehabilitation and prolonged recovery.^[@R1],[@R2]^ Regional anaesthesia has been proven to offer some advantages in this surgical setting. A continuous postoperative peripheral nerve block (PNB) (either femoral or adductor canal) after TKA helps to fulfil three specific discharge criteria: adequate analgesia, independence from intravenous opioids, and ambulation targets.^[@R3]--[@R6]^

Long-term rehabilitation following TKA is a subject of current interest, and chronic persistent postsurgical pain (PPSP) has been shown to be a problem common to a variety of surgical procedures.^[@R7]^ PPSP is a complex condition in which inflammatory, nociceptive and neuropathic components are involved.^[@R8]^ Its incidence varies widely, according to the type of surgery, and after TKA it ranges between 20 and 50% at 1 year.^[@R9],[@R10]^ Given the number of TKA performed every year^[@R11]^ a large number of individuals must be affected.

Among the risk factors for PPSP, the severity of acute postoperative pain is often listed. Those individuals who experience intense acute postoperative pain may be the ones most vulnerable to chronic PPSP and the severity of pre-operative pain is also a documented risk for PPSP development.^[@R7],[@R12],[@R13]^ TKA patients are doubly vulnerable being exposed to both factors: pre-operative pain is the main motivation for surgery, and TKA can be associated with severe postoperative pain. They are at high risk of PPSP, which serves to undermine their efforts and expectations, leaving them demoralised and disillusioned.

Regional anaesthesia can improve postoperative analgesia, but it is uncertain whether it can influence the development of chronic PPSP and improve long-term outcome.^[@R14]^

We performed this prospective observational study to evaluate the effects of different anaesthetic and analgesic techniques on both short-term and long-term outcome after TKA, with special interest on PPSP, functional outcome and the quality of life (QOL).

Methods
=======

The current prospective-based, observational-based, population-based multicentre registry was part of the bigger A.L.I.C.E. study (regional anaesthesia in Italy -- complications and outcomes) designed according to STROBE guidelines.^[@R15]^

The study received ethical approval from the coordinating centre (IRCCS Policlinico San Matteo, Pavia, Italy). It was approved by the collaborating institutions (ASST-Gaetano Pini-CTO -- Milano, Ospedale di Circolo-Varese, Ospedale Cottolengo-Torino, ASST-Monaldi-Napoli, Italy). The study was advertised in national anaesthesia meetings between 2012 and 2015, and at the ESRA Italian Chapter Annual Meeting. Any centre willing to participate was provided with all the documents needed for local approval, and a local representative was nominated to coordinate the project and take responsibility for data collection.

Patients to be included were scheduled for primary unilateral TKA, aged more than 18 years and able to give written and informed consent. Those with American Society of Anesthesiology (ASA) physical status class more than 3, those unable to give consent, and any undergoing bilateral TKA or with previous knee surgery were excluded.

Data were collected in a prospective fashion on universal case report forms used by all participants, which were sent to the coordinating centre quarterly.

Enrolment was at the pre-operative visit when the study was explained by either the surgeon or the anaesthesiologist and consent was obtained. Each patient was assigned with a code to protect privacy.

Data noted at the pre-operative visit included: age, sex, BMI, ASA class, the presence and intensity of pre-operative pain \[numerical rating scale (NRS) score both at rest and during walking\], and the risk factors for PPSP as currently understood. These are anxiety or depression, a pessimistic outlook, obesity, diabetes and pro-inflammatory conditions (immune/rheumatologic disease, headache, irritable bowel syndrome or inflammatory bowel diseases and fibromyalgia), low back pain with or without radicular symptoms and home therapy. The pre-operative ability to walk was also registered: no walking (\<50 m), poor walking (up to 500 m), good walking (between 500 and 1000 m) and unlimited (\>1000 m).

Data of both anaesthetic and the analgesic techniques were registered on the day of surgery: General and regional anaesthesia alone or combined, the use of local infiltration analgesia (LIA), as well as PNB, epidural analgesia, local anaesthetic infusion and adjuvants. An infusion of local anaesthetic was registered as 'continuous analgesia' only when lasting for more than 24 h. We also collected data regarding the use of steroids, NSAIDs, paracetamol and opioids.

Postoperative assessment included pain measured with NRS (11 point scale from 0 -- no pain to 10 -- worst imaginable pain) both at rest and moving (both active and passive knee flexion) analgesic consumption, postoperative complications (postoperative nausea and vomiting (PONV), neurological dysfunction, systemic infection, ischaemia and patient satisfaction at first (POD1) and second (POD2) postoperative day, and again on discharge.

An investigator blind to the data evaluated the presence of PPSP at 1, 3 and 6 months (defined as a NRS more than 3 either at rest or during daily activity, and the associated consumption of any analgesic drugs for knee pain), patient satisfaction (on a 1 to 10 scale), the subjective QOL and the walking distance using a standardised questionnaire (see appendix).

Statistical analysis
--------------------

The statistical analysis was performed with the dedicated software programme Stata 11.1 (StataCorp. LP, College Station, Texas, USA).

The primary outcome for this study was the incidence of PPSP. Secondary outcomes were the comparison of PPSP incidence by peri-operative regimen, the ability to walk, the QOL, patient satisfaction and the incidence of complications with respect to the type of peri-operative analgesia.

Given a reported incidence of PPSP between a minimum of 10% and a maximum of 50%,^[@R7]^ we planned to enrol a total of 600 patients. This sample size yields 95% confidence interval of 7.7 to 12.7% for the minimum incidence (10%) and of 44 to 54% for the maximum incidence (50%).

We built three different logistic regression models taking the following as the dependent variables: PPSP ('no'/'yes' if either daily analgesic consumption or NRS \> 3; since pain at rest was absent in all of the patients, movement-evoked pain was sought), improved autonomy ('no' if reduced or unchanged where restricted before surgery/'yes' if improved or unchanged where unrestricted before surgery) and improved health-related QOL ('no' if worsened or unchanged/'yes' if improved). Moreover, we built a linear regression model taking satisfaction (continuous on a 10-cm visual analogue scale) as the dependent variable.

These four predictive models were assembled for assessments taken 6 months after surgery. Similar models were implemented for assessments obtained on POD1, POD2 and 1 month after surgery for NRS more than 3.

Variable selection (likelihood ratio test or linear regression as appropriate, with *P* \< 0.20) was applied to the following variables: age, BMI, pre-operative NRS (continuous variables), sex, pre-operative inflammatory state, pre-operative lumbar pain (categorical no/yes variables), ASA status (I, II and III), type of anaesthesia (general, spinal and PNB) and postoperative use of regional analgesia \[none, single-shot PNB (ssPNB), continuous both epidural or PNB\]. In the final models, significance was set at *P* less than 0.05.

Results
=======

The current trial was registered on Clinicaltrials.gov (registration number NCT02147730).

Between January 2013 and April 2015, 614 patients were assessed for eligibility, and 563 of them completed the 6-month follow-up (Fig. [1](#F1){ref-type="fig"}). Of these, 421 (69.4%) were women and 185 were men. The median \[IQR (range)\] age was 72 \[67 to 77 (26 to 88)\], median BMI was 28 \[25 to 31 (16 to 41)\]. Thirty-three (5.4%) were ASA class 1, 510 (80.8%) were ASA class 2 and 58 (9.6%) were ASA class 3. Preoperative NRS was seven \[5 to 8 (0 to 10)\]. Our cohort reflects the general pattern of patients undergoing TKA.^[@R16]^
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General anaesthesia was given to 302 patients (50.2%), spinal anaesthesia to 263 (43.7%) and the remainder 36 (6.1%) received lumbar plexus + sciatic nerve block (PNB).

Six months after surgery 122/563 (21.6%) of patients reported PPSP. The ability to walk was improved in 317 (56.3%) and the QOL was worsened or unchanged in 173 (30.7%) and improved in 390 (69.3%).

Logistic regression identified the following independent risk factors for the evaluated 6-month outcomes (PPSP, walking distance, QOL and satisfaction): age, NRS more than 3 at 1 month, preoperative inflammatory status, BMI, anxiety-depression, ASA and the preoperative NRS (Table [1](#T1){ref-type="table"}).

For perioperative management, 50 (8.2%) patients did not receive any type of regional anaesthesia (noRA), 295 (48.7%) received a ssPNB, either femoral or femoral + sciatic nerve block, whereas 260 (42.7%) received a continuous local anaesthetic infusion (cPNB) defined as at least one peripheral nerve catheter as part of a femoral, lumbar plexus or adductor canal block, or an epidural catheter. Local infiltration analgesia (LIA) was infused in only 42 (6%) patients in the noRA group. In the cPNB group, seven (2%) patients received the local anaesthetic infusion for only 24 h due to the catheter being dislodged. In the remainder, the infusion was maintained for 48 (60% -- 158/260) or 72 h (37% -- 95/260). On POD1, POD2 and 1 month after surgery the continuous local anaesthetic infusion was a significant predictor of lower NRS compared with systemic analgesia or ssPNB (refer to multivariate logistic models in Table [2](#T2){ref-type="table"}). This difference ceased to reach significance at three and 6 months after surgery (Fig. [2](#F2){ref-type="fig"}).
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No difference was found between intraoperative anaesthesia modes and any evaluated long-term outcome. Patients receiving general anaesthesia showed an overall higher incidence of postoperative adverse effects (*P* = 0.002) compared with regional anaesthesia (spinal or lumbar plexus + sciatic nerve block), including PONV (18% -- 55/302 versus 7% -- 23/299), and major events such as acute cardiac ischaemia (three in general anaesthesia group and none in regional anaesthesia group) and deep venous thrombosis (three in general anaesthesia and two in regional anaesthesia).

All centres involved in the study used a multimodal analgesia protocol, including administration of NSAIDs beginning with intraoperative ketorolac in 62%, paracetamol in 68% and opioids (including tramadol) in 56% given as required or as rescue. Intra-operative dexamethasone was given to only 98 (16%) (mean dose 6.3 ± 2.2 mg). Characteristics of multimodal analgesia with respect the adopted regional anaesthesia are reported in Table [3](#T3){ref-type="table"}.

Discussion
==========

TKA is a complex procedure intended to improve the QOL. Unfortunately, it does not satisfy 20% of patients at 1 year after surgery and, unexpectedly, this percentage increases to 44% at 4 years after the procedure.^[@R9],[@R10]^ The primary cause of dissatisfaction is PPSP.^[@R17],[@R18]^ We report an incidence of PPSP of 21.6% 6 months after surgery (NRS \> 3 and/or daily consumption of analgesic for knee pain), and an unchanged or even worsened QOL in 30.7%. Our results are consistent with previous reports.^[@R9],[@R19]^

The main purpose of this study was to assess the influence of regional anaesthesia on the development of PPSP after TKA. We did not find any association between the type of anaesthesia and PPSP 6 months after surgery, even though continuous regional analgesia (both peripheral and epidural) significantly decreased pain in the early postoperative period up to 1 month compared with single-PNB. There was no difference in NRS between patients who were treated with ssPNB or without regional anaesthesia, with or without LIA. Taken together, these findings indicate the superiority of continuous techniques for postoperative analgesia, and that a ssPNB is not the best strategy for reducing postoperative pain and opioid consumption, the goals of fast-track perioperative care.

Our data suggest fewer postoperative complications in patients receiving regional anaesthesia compared with those receiving general. The superiority of regional anaesthesia in improving surgical outcome has been recently confirmed^[@R19]--[@R21]^; major complications after joint arthroplasty both unilateral and bilateral, were less common in all patient groups, irrespective of age and co-morbidity. Our data mainly show a reduction in the incidence of PONV, and the reduced risk of major complications is biased by the few cases (three cardiac ischaemia and five deep venous thromboses) that occurred during the study. Studies with the appropriate sample size are required to address this issue, but our data confirm the trend seen in previous large database studies.^[@R19]--[@R21]^

Some authors have recently questioned the role of continuous regional anaesthesia in the context of enhanced recovery after surgery: complications are a concern^[@R22],[@R23]^ and even minor side effects, particularly motor block, can derail the fast-track approach. But even if all goes well, the positive impact of enhanced recovery is reduced if the quality of the long-term outcome is impaired, as it is in those who experience PPSP. Our study suggests that the benefits of a continuous RA technique are extended beyond the pharmacological half-life, since pain relief is maintained for up to 1 month, potentially influencing the long-term outcome. This could prompt a reconsideration of the role of continuous RA techniques, since the drawbacks of the immediate postoperative period may be overcome by the long-term benefits.

Pain at 1 month was found to be an independent risk factor for PPSP at 6 months, in keeping with previous reports.^[@R7]^ In our study, the use of continuous regional anaesthesia as a part of a multimodal analgesia regimen significantly reduced the opioid requirement in the early postoperative period, and provided better pain control up to 1 month after surgery, making a continuous RA technique the first choice. Unfortunately, the superior analgesic efficacy of continuous regional anaesthesia was no longer in evidence at 3 and 6 months. The hypothesis that regional anaesthesia has a protective effect on PPSP is confirmed by our study; continuous regional anaesthesia produces superior analgesia in the immediate postoperative period, and the benefit extends from the peri-operative period to support rehabilitation. The reason for the lack of evidence of benefit of both continuous regional analgesia and the other groups at 3 and 6 months may be related to the quality of rehabilitation. Typically, rehabilitation in the early postoperative days is limited by pain^[@R4],[@R24]^ and is, therefore, dependent on the efficacy of postoperative analgesia. Beyond that, the success of TKA is strictly linked to rehabilitation, the standard of which varies according to the experience of the clinician. Rehabilitation after TKA has been defined as *the most useful and least studied practice.*^[@R25]^ Although it has a major impact on the global outcome it is often not investigated, and the confounding effect on published data may have been underestimated. The variability in the provision of physiotherapy may possibly hide clinically important differences in the analgesic techniques used in our study. Any attempt to overcome this bias will require a larger sample because of the low incidence of patients not receiving RA.

Our data also show other independent risk factors for PPSP. In common with earlier reports,^[@R12],[@R14]^ we found that a younger age and a history of anxiety or depression, in addition to the pro-inflammatory status, led to a higher incidence of PPSP and a 30% worsened health-related QOL 6 months after surgery. Other important factors in dissatisfaction were a higher BMI and a lower ASA physical status. Some of these factors are linked to expectation of TKA. The refusal rate for second stage surgery in bilateral TKA was 36.9%, when patients' expectations were unmet after the first intervention.^[@R26]^ A young and healthy patient with good baseline autonomy arguably displays a higher expectation towards the QOL and physical performance after surgery, which may sometimes be inconsistent with those provided by TKA. By contrast, an elderly patient with more comorbidities and severe arthritis will report a significant subjective relief with a smaller range of knee movement.^[@R27]^

We had previously investigated the association of the background inflammatory state and PPSP in minor surgery,^[@R28],[@R29]^ and this was confirmed here. Inflammation is a key mechanism in postoperative pain and central sensitisation. The pro-inflammatory response to the surgical trauma is believed to be particularly intense in patients with a higher baseline inflammatory status,^[@R30],[@R31]^ in whom pro-inflammatory and anti-inflammatory mechanisms are un-balanced by higher BMI, rheumatologic diseases or inflammatory bowel diseases. Further investigations are needed, but this is the first study, to our knowledge, suggesting such correlation.

The main strength of our study relies on the large sample size and in the prospective design. Our cohort is one of the largest ever presented in a study on PPSP after TKA, identifying a larger number of PPSP cases and allowing correlation with different types of anaesthesia and analgesia. The prospective nature of our study, together with the sample size improves on previous published reports on this topic.

A limitation of this study is the lack of a standardised postoperative analgesia protocol that could have better highlighted the effect of including different types of regional anaesthesia techniques. Our study was conceived as *multicentre and observational*, with each participating centre free to follow its own analgesic protocol. Nevertheless, the protocols in use in the five participating centres were broadly similar one to each other. Postoperative analgesia always included both paracetamol and NSAIDs, with opioid as rescue analgesic. Even if the multimodal protocols had included a broader spectrum of drugs (namely a larger use of dexamethasone),^[@R32],[@R33]^ our sample was homogeneously treated with respect to postoperative analgesia, thus reducing the confounding effect on our endpoints.

We did not provide data on duration of hospital stay, nor on the use of the fast-track regimen. Although relevant, we did not include them in our design which was slanted towards long-term outcome. However, the correlation between length of hospital stay, the use of continuous techniques and long-term outcome is worthy of a future study.

We did not use specific tests to evaluate functional status and QOL (such as Western Ontario and McMaster Universities Ostearthritis Index or Short Form 36 Health Survey) because we consider them time-consuming for both patients and researchers. Given the number of evaluations planned during the study, such specific questionnaires would have probably reduced compliance with follow-up evaluation. We acknowledge that the veracity of our findings may be partially undermined, but our approach was to obtain a large amount of data on the primary endpoint (PPSP and regional anaesthesia) rather than on secondary outcomes. Although this might attract criticism, there is still the option to use validated questionnaires in future studies of non-analgesic outcomes.

In conclusion our prospective, observational, multicentre study demonstrated that continuous regional anaesthesia techniques significantly improve postoperative analgesia after TKA, maintaining superior pain relief for up to 1 month after surgery compared with multimodal analgesia without regional anaesthesia or with a ssPNB. We also found that PPSP was present 6 months after surgery in 21.6% of patients irrespective of the type of anaesthesia and analgesia. We identified younger age, anxiety or depression, and pre-inflammatory status as independent risk factors for PPSP with a worsened QOL. Future studies should address the correlation between the type and timing of continuous regional anaesthesia and long-term rehabilitation to extend the benefit of analgesia over the first month.
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###### 

Predictive model for persistent postsurgical pain, quality of life, ability to walk and satisfaction 6 months after total knee arthroplasty

  Dependent variable   Predictors                                                                         
  -------------------- -------------------------------------------- -------------------------- ---------- -----------------------------
  PPSP                                                              OR (95% CI)                *P*        Whole-model *P*
                       Age                                          0.977 (0.956 to 0.998)     0.025      \<0.0001
                       NRS \> 3 1 month after surgery               3.710 (2.305 to 5.974)     \<0.0001   
  QOL                                                               OR (95% CI)                *P*        Whole-model *P*
                       Preoperative NRS                             1.195 (1.093 to 1.306)     \<0.0001   \<0.0001
                       Inflammation                                 0.448 (0.237 to 0.847)     0.014      
  Walking distance                                                  OR (95% CI)                *P*        Whole-model *P*
                       ASA \> 1[^a^](#TF1-1){ref-type="table-fn"}   2.783 (1.103 to 7.026)     0.030      0.030
  Satisfaction                                                      Coeff. (95% CI)            *P*        Whole-model *P*/Adj. *R*^2^
                       Anxiety/depression                           −0.346 (−0.652 to 0.040)   0.027      0.0035/0.0167
                       BMI                                          0.035 (0.006 to 0.063)     0.017      

ASA, American Society of Anesthesiologists; CI, confidence interval; NRS, numerical rating scale; OR, odds ratio; PPSP, persistent postsurgical pain; QOL, quality of life.

^a^ASA II did not differ from ASA III, whereas both ASA II and III differed from ASA I. Hence ASA has been recoded into ASA \> 1 (no/yes).

###### 

Predictive model for NRS more than 3 both at rest and incident on first postoperative day, second postoperative day and 1 month after total knee arthroplasty

                          Dependent variable    Predictors             OR (95% CI)              *P*       Whole-model *P*
  ----------------------- --------------------- ---------------------- ------------------------ --------- -----------------
  POD1                    NRS \> 3 (rest)       Preoperative pain      1.447 (1.010 to 2.073)   0.044     0.0001
                                                Continuous analgesia   0.476 (0.454 to 0.905)   \<0.001   
                          NRS \> 3 (incident)   Preoperative NRS       0.904 (0.830 to 0.984)   0.020     0.0030
                                                Continuous analgesia   0.640 (0.453 to 0.904)   0.011     
  POD2                    NRS \> 3 (rest)       Preoperative pain      1.893 (1.300 to 2.758)   0.001     0.0001
                                                Continuous analgesia   0.567 (0.386 to 0.834)   0.004     
                          NRS \> 3 (incident)   Continuous analgesia   0.629 (0.448 to 0.884)   0.008     0.008
  1 month after surgery   NRS \> 3 (rest)       No model                                                  
                          NRS \> 3 (incident)   Male sex               0.567 (0.392 to 0.821)   0.003     \<0.0001
                                                BMI                    0.944 (0.906 to 0.983)   0.005     
                                                Continuous analgesia   0.616 (0.907 to 0.983)   0.005     

CI, confidence interval; NRS, numerical rating scale; OR, odds ratio; POD1, first postoperative day; POD2, second postoperative day.

###### 

Perioperative management with respect to the use of multimodal analgesia in patients receiving single-shot peripheral nerve block, continuous peripheral nerve block or any type of regional anaesthesia

  Analgesia groups   NSAIDs, *n* (%)   Paracetamol, *n* (%)   Opioids, *n* (%)   LAI, *n* (%)   Dexamethasone, *n* (%)
  ------------------ ----------------- ---------------------- ------------------ -------------- ------------------------
  noRA               45 (90)           44 (88)                43 (82)            42 (84)        42 (84)
  ssPNB              203 (69)          200 (68)               216 (73)           --             44 (14)
  cPNB               123 (47)          168 (64)               76 (29)            --             12 (4)

cPNB, continuous peripheral nerve block; noRA, any type of regional anaesthesia; ssPNB, single-shot peripheral nerve block.
